Viewing Study NCT00312364



Ignite Creation Date: 2024-05-05 @ 4:47 PM
Last Modification Date: 2024-10-26 @ 9:24 AM
Study NCT ID: NCT00312364
Status: COMPLETED
Last Update Posted: 2012-06-01
First Post: 2006-04-06

Brief Title: Safety and Efficacy Study of MRE0094 to Treat Chronic Neuropathic Diabetic Foot Ulcers
Sponsor: Pfizer
Organization: Pfizer

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2012-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This is a clinical research study of an experimental topical drug for the treatment of chronic neuropathic diabetic foot ulcers

Patients participating in the study may receive an active drug MRE0094 inactive drug placebo or a gel used to treat diabetic foot ulcers currently available for sale in the United States What treatment a patient will receive is determined by chance like drawing a number from a hat All patients will receive additional care for diabetic foot ulcers during the study

Participation in the study can be up to 4½ months
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None